Aptar Pharma's announces progress on research contract with U.S. FDA on advancing scientific understanding related to transition of MDIs toward NGPs.

In the latest legal development in the ongoing 340B contract pharmacy litigation, the United States Court of Appeals for the District of Columbia Circuit ruled earlier this week that the 340B Drug ...

(Reuters) - Cardinal Health said on Monday its contracts with UnitedHealth Group's OptumRx, one of its largest customers, will not be renewed after they expire at the end of June, sending the drug ...

The US Food and Drug Administration (FDA) has issued warning letters to a contract drug maker for failing to meet current good manufacturing practices (CGMP) and a clinical investigator for failing to ...

In 2021, we provided an overview of multiple federal lawsuits challenging the US Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) enforcement of the ...

McKesson Corp. is in a contest with Cardinal Health Inc. and AmerisourceBergen Corp. for a U.S. Department of Veterans Affairs drug distributor contract worth as much as $32 billion. "It is really a ...